Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt.

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing ...

A groundbreaking project to study potential HIV vaccines in several ... to the development of SARS-CoV-2 vaccines made by the pharmaceutical companies Moderna and Pfizer/BioNTech.

MORE: Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS The opposition ... from melanoma to HIV to Zika, according to clinical trials. The proposed bans ...

Moderna (MRNA) and other vaccine maker stocks plummeted during pre-market trading on Monday amid news from this weekend that the Food and Drug Administration’s (FDA) top vaccine regulator was ...

Moderna (MRNA) announced that the Australian Therapeutic Goods Administration has granted approval for mRESVIA, an mRNA respiratory syncytial ...

There’s also ongoing work on a potential HIV vaccine. To find out more about HIV drugs that are currently available (and those that may become available in the future), talk with a healthcare ...

“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...